BRPI0211282B8 - curativo compreendendo composição de fluido de silicone não volátil e seu método de manufatura, uso de composição para tratamento de cicatriz e de infecção por patógeno, bem como aplicador - Google Patents

curativo compreendendo composição de fluido de silicone não volátil e seu método de manufatura, uso de composição para tratamento de cicatriz e de infecção por patógeno, bem como aplicador

Info

Publication number
BRPI0211282B8
BRPI0211282B8 BRPI0211282A BR0211282A BRPI0211282B8 BR PI0211282 B8 BRPI0211282 B8 BR PI0211282B8 BR PI0211282 A BRPI0211282 A BR PI0211282A BR 0211282 A BR0211282 A BR 0211282A BR PI0211282 B8 BRPI0211282 B8 BR PI0211282B8
Authority
BR
Brazil
Prior art keywords
composition
scarring
dressing
applicator
manufacture
Prior art date
Application number
BRPI0211282A
Other languages
English (en)
Other versions
BR0211282B1 (pt
BR0211282A (pt
Inventor
Berlat Alvin
Original Assignee
Advanced Biotechnologies Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Advanced Biotechnologies Inc filed Critical Advanced Biotechnologies Inc
Publication of BR0211282A publication Critical patent/BR0211282A/pt
Publication of BR0211282B1 publication Critical patent/BR0211282B1/pt
Publication of BRPI0211282B8 publication Critical patent/BRPI0211282B8/pt

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/02—Inorganic compounds
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61L—METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
    • A61L26/00—Chemical aspects of, or use of materials for, wound dressings or bandages in liquid, gel or powder form
    • A61L26/0061—Use of materials characterised by their function or physical properties
    • A61L26/0066—Medicaments; Biocides
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61L—METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
    • A61L26/00—Chemical aspects of, or use of materials for, wound dressings or bandages in liquid, gel or powder form
    • A61L26/0004—Chemical aspects of, or use of materials for, wound dressings or bandages in liquid, gel or powder form containing inorganic materials
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61L—METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
    • A61L26/00—Chemical aspects of, or use of materials for, wound dressings or bandages in liquid, gel or powder form
    • A61L26/0009—Chemical aspects of, or use of materials for, wound dressings or bandages in liquid, gel or powder form containing macromolecular materials
    • A61L26/0019—Chemical aspects of, or use of materials for, wound dressings or bandages in liquid, gel or powder form containing macromolecular materials obtained otherwise than by reactions only involving carbon-to-carbon unsaturated bonds
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00—Drugs for dermatological disorders
    • A61P17/02—Drugs for dermatological disorders for treating wounds, ulcers, burns, scars, keloids, or the like
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/04—Antibacterial agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/10—Antimycotics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/12—Antivirals
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61L—METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
    • A61L2300/00—Biologically active materials used in bandages, wound dressings, absorbent pads or medical devices
    • A61L2300/10—Biologically active materials used in bandages, wound dressings, absorbent pads or medical devices containing or releasing inorganic materials
    • A61L2300/102—Metals or metal compounds, e.g. salts such as bicarbonates, carbonates, oxides, zeolites, silicates
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61L—METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
    • A61L2300/00—Biologically active materials used in bandages, wound dressings, absorbent pads or medical devices
    • A61L2300/10—Biologically active materials used in bandages, wound dressings, absorbent pads or medical devices containing or releasing inorganic materials
    • A61L2300/102—Metals or metal compounds, e.g. salts such as bicarbonates, carbonates, oxides, zeolites, silicates
    • A61L2300/104—Silver, e.g. silver sulfadiazine
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61L—METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
    • A61L2300/00—Biologically active materials used in bandages, wound dressings, absorbent pads or medical devices
    • A61L2300/40—Biologically active materials used in bandages, wound dressings, absorbent pads or medical devices characterised by a specific therapeutic activity or mode of action
    • A61L2300/404—Biocides, antimicrobial agents, antiseptic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61L—METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
    • A61L2300/00—Biologically active materials used in bandages, wound dressings, absorbent pads or medical devices
    • A61L2300/80—Biologically active materials used in bandages, wound dressings, absorbent pads or medical devices characterised by a special chemical form
    • A61L2300/802—Additives, excipients, e.g. cyclodextrins, fatty acids, surfactants

Abstract

"formulação farmacêutica tópica". a presente invenção se refere a uma composição compreendendo fluido de silicone não volátil em mistura com fumos de sílica e um agente farmaceuticamente ativo.
BRPI0211282A 2001-07-24 2002-07-23 curativo compreendendo composição de fluido de silicone não volátil e seu método de manufatura, uso de composição para tratamento de cicatriz e de infecção por patógeno, bem como aplicador BRPI0211282B8 (pt)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US30754801P 2001-07-24 2001-07-24
PCT/GB2002/003387 WO2003009877A1 (en) 2001-07-24 2002-07-23 Topical pharmaceutical formulation

Publications (3)

Publication Number Publication Date
BR0211282A BR0211282A (pt) 2004-08-03
BR0211282B1 BR0211282B1 (pt) 2018-01-09
BRPI0211282B8 true BRPI0211282B8 (pt) 2021-05-25

Family

ID=23190223

Family Applications (1)

Application Number Title Priority Date Filing Date
BRPI0211282A BRPI0211282B8 (pt) 2001-07-24 2002-07-23 curativo compreendendo composição de fluido de silicone não volátil e seu método de manufatura, uso de composição para tratamento de cicatriz e de infecção por patógeno, bem como aplicador

Country Status (21)

Country Link
US (1) US8263114B2 (pt)
EP (1) EP1409034B1 (pt)
JP (1) JP3778559B2 (pt)
KR (1) KR101009267B1 (pt)
CN (1) CN1234426C (pt)
AT (1) ATE331537T1 (pt)
AU (1) AU2002317981B2 (pt)
BR (1) BRPI0211282B8 (pt)
CA (1) CA2454673C (pt)
DE (1) DE60212847T2 (pt)
DK (1) DK1409034T3 (pt)
ES (1) ES2268061T3 (pt)
HK (1) HK1061362A1 (pt)
IL (2) IL160109A0 (pt)
MX (1) MXPA04000444A (pt)
NO (1) NO334175B1 (pt)
NZ (1) NZ529957A (pt)
PT (1) PT1409034E (pt)
RU (1) RU2306121C2 (pt)
WO (1) WO2003009877A1 (pt)
ZA (1) ZA200400488B (pt)

Families Citing this family (31)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US20070237834A1 (en) * 2003-04-18 2007-10-11 Bioderm Research Zinc Zeolite for the Treatment for Diaper Rash (Diaper Dermatitis)
PT1648826T (pt) * 2003-07-03 2017-11-14 The Univ Court Of The Univ Of St Andrews Zeólitos para a administração de óxido nítrico
KR101528918B1 (ko) * 2004-11-07 2015-06-15 쿠프론 인코포레이티드 상처, 화상 및 다른 피부 질환을 치료하기 위한 구리 함유물질
CA2637447A1 (en) * 2006-01-30 2007-08-02 Sanjeev Kaila A composition including a silicone-based polymer and a method of treating skin disorders using the composition
US8427076B2 (en) * 2007-06-29 2013-04-23 Carmanah Technologies Corp. Intelligent area lighting system
UA28103U (uk) * 2007-07-12 2007-11-26 Ольга Олександрівна Біляєва Комплексний сорбційно-протеолітичний препарат сертасил для лікування гнійних ран, трофічних виразок, опіків
GB0821345D0 (en) * 2008-11-21 2008-12-31 P Q Silicas Uk Ltd Composition and dressing with nitric oxide
WO2010079209A2 (en) * 2009-01-08 2010-07-15 Golub Alexandr A Compositions for treating wounds and skin conditions
US20100322875A1 (en) * 2009-06-18 2010-12-23 Advanced Bio-Technologies, Inc. Silicone scar treatment preparation
RU2012104912A (ru) * 2009-07-17 2013-08-27 КЕЭ-ФЬЮЖН 2200, Инк. Частицы, содержащие противомикробные агенты
RU2429820C2 (ru) * 2009-09-24 2011-09-27 Закрытое акционерное общество "Институт прикладной нанотехнологии" (ЗАО"ИПН") Антисептическая мазь наружного применения (2 варианта)
RS63043B1 (sr) 2009-11-03 2022-04-29 Lipidor Ab Kompozicija koja obrazuje lipidni sloj za primenu na površinu živog organizma
JP2013510085A (ja) * 2009-11-03 2013-03-21 リピドール エービー 創傷治療促進用組成物
US10500173B2 (en) * 2010-06-17 2019-12-10 Covalon Technologies Inc. Antimicrobial silicone-based wound dressings
WO2012150890A1 (en) * 2011-05-02 2012-11-08 Lipidor Ab Antibacterial composition
US20130144225A1 (en) 2011-12-06 2013-06-06 Jessica Rowen Method And Device For Scar Management
TWI474823B (zh) * 2013-09-25 2015-03-01 Far Eastern New Century Corp 疤痕凝膠的組成物
US9226890B1 (en) 2013-12-10 2016-01-05 Englewood Lab, Llc Polysilicone base for scar treatment
US11039621B2 (en) 2014-02-19 2021-06-22 Corning Incorporated Antimicrobial glass compositions, glasses and polymeric articles incorporating the same
US9622483B2 (en) 2014-02-19 2017-04-18 Corning Incorporated Antimicrobial glass compositions, glasses and polymeric articles incorporating the same
US11039620B2 (en) 2014-02-19 2021-06-22 Corning Incorporated Antimicrobial glass compositions, glasses and polymeric articles incorporating the same
CN106729963A (zh) * 2016-12-22 2017-05-31 苏州迈达医疗器械有限公司 一种硅酮凝胶敷料及其生产工艺
US10496949B2 (en) 2017-01-04 2019-12-03 Christopher Zoumalan Compositions and methods for treating cutaneous conditions
RU2674445C1 (ru) * 2017-12-11 2018-12-10 Федеральное государственное бюджетное военное образовательное учреждение высшего образования Военно-медицинская академия имени С.М. Кирова Министерства обороны Российской Федерации (ВМедА) Спрей для наружного применения спиртовой
CN108714141A (zh) * 2018-05-29 2018-10-30 南京华开生物科技有限公司 硅酮疤痕喷剂
CN112839998B (zh) * 2018-07-26 2022-11-18 伊克赛腾药业股份有限公司 用于氧化剂的媒介物和递送系统
CA3115032A1 (en) * 2018-09-26 2020-04-02 Exaltexx Inc. Winterized maturing agent, viscosity reducer and production enhancer
US11433016B2 (en) 2019-03-28 2022-09-06 L'oreal Cosmetic compositions for skin
US11364190B2 (en) 2019-07-30 2022-06-21 L'oreal Acid perfluoro-free self-foaming facial cleanser composition
US11207255B2 (en) 2019-07-30 2021-12-28 L'oreal Perfluoro-free self-foaming facial cleanser composition
US11213473B1 (en) 2020-09-18 2022-01-04 Christopher Zoumalan Skin brightening composition

Family Cites Families (18)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPH0618899B2 (ja) * 1987-06-30 1994-03-16 品川燃料株式会社 抗菌性ゼオライト含有フィルム
US5292530A (en) * 1991-06-02 1994-03-08 Helene Curtis, Inc. Stable anhydrous topically-active composition and suspending agent therefor
JPH049327A (ja) 1990-04-04 1992-01-14 Kootec Kk 創傷被覆材
FR2678513B1 (fr) 1991-07-03 1995-06-30 Laboratoires Hygiene Dietetique Pansement cicatrisant.
AU6525296A (en) 1995-07-19 1997-02-18 Innovative Technologies Limited Wound treatment composition
US5833998A (en) 1995-11-06 1998-11-10 The Procter & Gamble Company Topical compositions for regulating the oily/shiny appearance of skin
JPH09194350A (ja) 1996-01-19 1997-07-29 Morishita Jintan Kk 創傷被覆材
US6231259B1 (en) 1996-07-26 2001-05-15 The Gillette Company Viscous product dispenser with porous dome
US5741509A (en) * 1996-08-26 1998-04-21 Alvin S. Berlat Silicone wound dressing
WO1999030629A1 (en) * 1997-12-17 1999-06-24 Hemodynamics, Inc. Sealing media for surgery and wound closure
US6183766B1 (en) 1999-02-12 2001-02-06 The Procter & Gamble Company Skin sanitizing compositions
DE60013098T2 (de) 1999-02-12 2005-09-01 The Procter & Gamble Company, Cincinnati Zusammensetzung zur hautdesinfizierung
GB0007140D0 (en) 1999-09-27 2000-05-17 Dow Corning Sa Scar treatment composition
WO2001089464A1 (en) 2000-05-23 2001-11-29 Unilever Plc Deodorant and/or antiperspirant compositions
US8486374B2 (en) 2003-08-04 2013-07-16 Foamix Ltd. Hydrophilic, non-aqueous pharmaceutical carriers and compositions and uses
US20060110415A1 (en) 2004-11-22 2006-05-25 Bioderm Research Topical Delivery System for Cosmetic and Pharmaceutical Agents
US20080292560A1 (en) 2007-01-12 2008-11-27 Dov Tamarkin Silicone in glycol pharmaceutical and cosmetic compositions with accommodating agent
DK2211919T3 (da) 2007-09-30 2011-12-12 Meda Ab Siliconegelbaserede sammensætninger til sårheling og armindskning

Also Published As

Publication number Publication date
HK1061362A1 (en) 2004-09-17
JP3778559B2 (ja) 2006-05-24
WO2003009877A1 (en) 2003-02-06
BR0211282B1 (pt) 2018-01-09
PT1409034E (pt) 2006-11-30
EP1409034A1 (en) 2004-04-21
DE60212847T2 (de) 2007-06-14
RU2306121C2 (ru) 2007-09-20
ZA200400488B (en) 2005-06-29
KR20040032864A (ko) 2004-04-17
NO20040319L (no) 2004-01-23
KR101009267B1 (ko) 2011-01-18
DE60212847D1 (de) 2006-08-10
US20040234474A1 (en) 2004-11-25
CN1527729A (zh) 2004-09-08
NZ529957A (en) 2005-11-25
RU2004105164A (ru) 2005-06-27
MXPA04000444A (es) 2004-10-27
EP1409034B1 (en) 2006-06-28
IL160109A0 (en) 2004-06-20
CA2454673A1 (en) 2003-02-06
CA2454673C (en) 2011-04-26
JP2005502639A (ja) 2005-01-27
ES2268061T3 (es) 2007-03-16
DK1409034T3 (da) 2006-10-30
BR0211282A (pt) 2004-08-03
ATE331537T1 (de) 2006-07-15
CN1234426C (zh) 2006-01-04
US8263114B2 (en) 2012-09-11
IL160109A (en) 2008-04-13
AU2002317981B2 (en) 2006-12-07
NO334175B1 (no) 2014-01-06

Similar Documents

Publication Publication Date Title
BRPI0211282B8 (pt) curativo compreendendo composição de fluido de silicone não volátil e seu método de manufatura, uso de composição para tratamento de cicatriz e de infecção por patógeno, bem como aplicador
CY1105626T1 (el) Σκευασματα τυπου φυραματος που περιλαμβανουν διοξειδιο πυριτιου
SE0101387D0 (sv) Novel compounds
SV2002000245A (es) Oxazolidinonas substituidas y su uso ref. lea 34122-sv
HRP20040059B1 (en) Treatment of nail infections with no
BR0210840A (pt) Composição de formação de pelìcula substancialmente anìdrica, artigo e artigo absorvente descartável que compreende a mesma
NO20035743L (no) Substituerte oksazolindinoner for kombinasjonsterapi
BRPI0304933B8 (pt) curativo de ferida, processo de manufatura do mesmo e uso do dito curativo de ferida para a manufatura de um medicamento para tratamento profilático e/ou curativo de uma condição médica
NI200800169A (es) Uso de derivados de sulfamidas heterocíclicas benzo-fusionadas para el tratamiento del dolor
AR036652A1 (es) Composiciones para el tratamiento del cabello que brindan cuerpo al cabello y que comprenden adhesivos sensibles a la presion de la silicona
CL2011003327A1 (es) Composicion farmaceutica que comprende finafloxacina y un agente antiinflamatorio; uso en el tratamiento de infecciones oftalmicas, oticas o nasales.
BR0208411A (pt) Composto, composição farmacêutica tópica e método para tratamento profilático ou terapêutico de doenças sexualmente transmitidas em um paciente humano, e, uso de um composto
BR0307899A (pt) Oxa- e tiadiazóis e seu uso como inibidores de metaloproteinase
AR043220A1 (es) Articulo absorbente, y uso de gel de polisiloxano
CL2008001279A1 (es) Metodo para mejorar la actividad antimicrobiana de una formulacion que comprende un aminoacido n-halogenado que comprende un agente de transferencia de fase; formulacion; metodo para desinfectar superficies y lentes de contacto; metodo para tratar una infeccion de tejido y para tratar infecciones respiratorias.
SE0004101D0 (sv) New use
SE0103276L (sv) Anordning för administrering av salva till en hudyta
AR035600A1 (es) Uso de agonistas selectivos del receptor de dopamina d4 en la fabricacion de medicamentos para tratar la disfuncion sexual
DE602005021095D1 (de) Antimikrobielle zusammensetzungen und ihre verwendungen
BR0109896A (pt) Composição tópica em gel, curativo de feridas, seu método e uso
ITRM20060094A1 (it) Uso della piperacillina in preparati topici intravaginali per il trattamento di infezioni vaginali batteriche ginecologiche ed ostetriche
EE200300507A (et) HIV proteaasi inhibiitorite kasutamine rakkude migratsiooni ja/või invasiooni, koe infiltratsiooni ja turse tekkimise blokeerimiseks
BG106430A (en) Liquid mucoadhesive pharmaceutical composition
ITFO20020011A0 (it) Strumento di cannula vaginale atto ad eseguire irrigazioni vaginali con successiva somministrazione in vagina di principi attivi in formulaz
RS52718B (en) ALBUMIN AND / OR MANITOL FOR THE TREATMENT OF NASAL POLYPOSIS

Legal Events

Date Code Title Description
B06F Objections, documents and/or translations needed after an examination request according [chapter 6.6 patent gazette]
B07D Technical examination (opinion) related to article 229 of industrial property law [chapter 7.4 patent gazette]
B07E Notification of approval relating to section 229 industrial property law [chapter 7.5 patent gazette]
B06A Patent application procedure suspended [chapter 6.1 patent gazette]
B09A Decision: intention to grant [chapter 9.1 patent gazette]
B16A Patent or certificate of addition of invention granted [chapter 16.1 patent gazette]
B16C Correction of notification of the grant [chapter 16.3 patent gazette]

Free format text: PRAZO DE VALIDADE: 20 (VINTE) ANOS CONTADOS A PARTIR DE 23/07/2002 OBSERVADAS AS CONDICOES LEGAIS. PATENTE CONCEDIDA CONFORME ADI 5.529/DF

B21A Patent or certificate of addition expired [chapter 21.1 patent gazette]

Free format text: PATENTE EXTINTA EM 23/07/2022